患者特征对关节镜下Bankart修复术后最小临床重要差异和患者可接受症状状态阈值的影响
这项回顾性病例系列研究纳入190例关节镜下Bankart修复术后患者,估算术后1年Rowe与ASOSS评分的MCID和PASS阈值并分析患者特征的影响。Rowe与ASOSS的MCID分别为8.2和8.7,PASS阈值分别为≥80和≥90;阈值随性别、年龄、运动参与和运动员类型呈现较大变异。
要点
- 关节镜下Bankart修复术后1年Rowe评分MCID为8.2、ASOSS评分MCID为8.7。
- 术后1年Rowe评分PASS阈值为≥80、ASOSS评分PASS阈值为≥90。
- MCID与PASS阈值随性别、年龄、运动参与和运动员类型呈现较大变异。
核心结论
- 本研究确定了关节镜下Bankart修复术后1年Rowe和ASOSS评分的MCID与PASS阈值,但按性别、年龄、运动参与和运动员类型分层时这些值呈现较大变异,作者强调应考虑患者个体特征以优化治疗决策并使治疗成功契合每位患者的需求和期望。
研究设计与样本
- 研究为病例系列,证据等级4级。
- 回顾性审查单家机构2017年1月至2020年1月接受关节镜下Bankart修复术的患者,纳入至少1次不稳发作且随访至少12个月者,共纳入190例患者。
- 排除标准包括:术前CT示肩胛盂前下部骨缺损>20%、关节镜检查示外展90°和外旋90°时存在engage型Hill-Sachs损伤、同侧肩既往手术、多向不稳或合并全层肩袖撕裂修复、上盂唇前后部损伤、后盂唇撕裂或肱骨头撕脱肩关节囊韧带损伤。
- 术前和术后1年收集患者报告结局指标,Delta定义为术前与术后1年评分的差值。
- 采用基于分布的方法(术前与术后结局评分差值标准差的一半)估算MCID,采用基于锚定的方法(术后1年对满意度问题的应答)估算PASS,并计算敏感度和特异度最大化的最佳截断点及达到各阈值的患者百分比。
主要发现
- Rowe和ASOSS评分的基于分布的MCID分别为8.2和8.7。
- 达到MCID阈值的患者比例Rowe为96%、ASOSS为96%。
- Rowe和ASOSS评分的PASS阈值分别为≥80和≥90,术后达到PASS的患者比例分别为86%和83%。
- 按性别分层,男性Rowe的MCID为8.5、PASS为≥85,ASOSS的MCID为8.9、PASS为≥90;女性Rowe的MCID为6.7、PASS为≥73,ASOSS的MCID为8.1、PASS为≥75。
- 按年龄分层,≥21岁者Rowe的MCID为8.4、PASS为≥80,ASOSS的MCID为9.2、PASS为≥90;<21岁者Rowe的MCID为7.8、PASS为≥75,ASOSS的MCID为7.7、PASS为≥85。
关键数值与推荐
- Rowe评分MCID为8.2,ASOSS评分MCID为8.7。
- Rowe评分PASS阈值为≥80,ASOSS评分PASS阈值为≥90。
- 达到MCID的患者比例Rowe为96%、ASOSS为96%;达到PASS的患者比例Rowe为86%、ASOSS为83%。
- 男性Rowe的MCID为8.5、PASS为≥85,ASOSS的MCID为8.9、PASS为≥90;女性Rowe的MCID为6.7、PASS为≥73,ASOSS的MCID为8.1、PASS为≥75。
- ≥21岁者Rowe的MCID为8.4、PASS为≥80,ASOSS的MCID为9.2、PASS为≥90;<21岁者Rowe的MCID为7.8、PASS为≥75,ASOSS的MCID为7.7、PASS为≥85。
临床怎么用
- 原文未据此给出推荐。
局限性
- 研究为单家机构的回顾性审查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: There is scarce literature on clinically significant values after arthroscopic Bankart repair (ABR). PURPOSE: To determine the minimal clinically important difference (MCID) and the patient acceptable symptom state (PASS) thresholds at 1 year for the Rowe and Athletic Shoulder Outcome Scoring System (ASOSS) scores after ABR and to determine the effect of patient characteristics on these metrics after ABR. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A retrospective review of patients undergoing ABR from a single institution between January 2017 and January 2020 was performed. Patients with at least 1 episode of instability and a minimum follow-up of 12 months were included. The exclusion criteria were as follows: bony defects of >20% on the anteroinferior portion of the glenoid based on a preoperative computed tomography scan; engaging Hill-Sachs lesions at 90° of abduction and 90° of external rotation based on an arthroscopic examination; previous surgery on the same shoulder; multidirectional instability or concomitant repair of full-thickness rotator cuff tears; superior labral anterior to posterior lesions; posterior labral tears; or humeral avulsion of the glenohumeral ligament lesions. Patient-reported outcome measures were collected both preoperatively and 1-year postoperatively. Delta was defined as the change between preoperative and 1-year postoperative scores. Distribution-based (one-half the standard deviation of the difference between pre- and postoperative outcome scores) and anchored-based approaches (response to a satisfaction question at 1 year) were used to estimate the MCID and the PASS, respectively. The optimal cutoff point, where sensitivity and specificity were maximized, and the percentage of patients achieving those thresholds were also calculated. RESULTS: Overall, 190 patients were included. The distribution-based MCID for the Rowe and ASOSS scores were calculated to be 8.2 and 8.7, respectively. The rate of patients who achieved MCID thresholds was 96% for the Rowe and 96% for ASOSS scores. The PASS threshold for the Rowe and ASOSS scores were ≥80 and ≥90, respectively. The rate of patients who achieved PASS scores after ABR were 86% and 83%, respectively. The MCID and PASS values showed great variability based on sex (men: 8.5 and ≥85 for Rowe / 8.9 and ≥90 for ASOSS, respectively, vs women: 6.7 and ≥73 for Rowe / 8.1 and ≥75 for ASOSS), age (≥21: 8.4 and ≥80 / 9.2 and ≥90 vs <21: 7.8 and ≥75 / 7.7 and ≥85), sports participation (sports: 8.8 and ≥85 / 9.5 and ≥90 vs no sports: 8.1 and ≥75 / 8.6 and ≥80), and type of athlete (competitive: 8.4 and ≥85 / 8.9 and ≥87 vs recreational: 7.5 and ≥73 / 8.1 and ≥68). CONCLUSION: This study identified the MCID and PASS thresholds for the Rowe and ASOSS scores at 1 year after ABR. However, these values showed great variability when accounting for different patient characteristics such as sex, age, sports participation, and type of athlete, highlighting the importance of considering individual patient-specific characteristics for optimal treatment decision-making and ensuring treatment success tailored to each patient's unique needs and expectations.
引用
- Pasqualini I, Tanoira I, Hurley ET, et al. Effect of Patient Characteristics on the Minimal Clinically Important Difference and Patient Acceptable Symptom State Thresholds After Arthroscopic Bankart Repair. Am J Sports Med. 2024. PMID: 38164674. doi:10.1177/03635465231212652
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。